polyclonal rabbit anti-human transferrin antibodies (Agilent technologies)
Structured Review
Polyclonal Rabbit Anti Human Transferrin Antibodies, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+rabbit+anti-human+transferrin+antibody/pm30641270-63-8-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Glycosylation Analysis for Congenital Disorders of Glycosylation. Article Snippet: Congenital disorders of glycosylation (CDG) are a group of diseases with highly variable phenotypes and inconsistent clinical features.. Since the first description of a CDG in 1980, approximately 100 disorders have been identified.. Most of these are defects in protein glycosylation, although an increasing number are defects of glycolipid or proteoglycan biosynthesis. |

